LUSTRE: A Phase III Randomized Trial of Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Hypofractionated Radiotherapy (CRT) for Medically Inoperable Stage I Non-Small Cell Lung Cancer (NSCLC)

Oct 17, 2022
5:30PM to 6:30PM

Event Categories ECRI seminars

Date/Time
Date(s) - 17/10/2022
5:30 pm - 6:30 pm

Topic:	LUSTRE: A Phase III Randomized Trial of Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Hypofractionated Radiotherapy (CRT) for Medically Inoperable Stage I Non-Small Cell Lung Cancer (NSCLC)
Speaker:	Anand Swaminath Radiation Oncologist, JCC

For people who would like to join, please contact ecri@mcmaster.ca to be added to the update.